CXCR5 and non-Hodgkin lymphoma: In conclusion, we observe increased differentiation of CXCR5+PD‐1+ CD8 T cells combined with a lower expression of PD‐1 in CLL, but not in other NHL with better response rates to PD‐1 ICB.